{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:13:47Z","timestamp":1751429627880,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea government","award":["2022R1F1A1063027"],"award-info":[{"award-number":["2022R1F1A1063027"]}]},{"name":"Ulsan University Hospital Research Grant"},{"name":"Ministry of Health & Welfare, Republic of Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04964-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:19:14Z","timestamp":1751375954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential impact of lipoprotein(a) on subclinical coronary atherosclerosis in asymptomatic individuals with and without diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3246-7104","authenticated-orcid":false,"given":"Mi-Hee","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-8029","authenticated-orcid":false,"given":"Sangwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-4298","authenticated-orcid":false,"given":"Soe Hee","family":"Ann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-9025","authenticated-orcid":false,"given":"Yong-Giun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8070-2453","authenticated-orcid":false,"given":"Young-Jee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0922-6677","authenticated-orcid":false,"given":"Soyeoun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8803-0049","authenticated-orcid":false,"given":"Woon Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7292-6844","authenticated-orcid":false,"given":"Seong Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-8072","authenticated-orcid":false,"given":"Seungbong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5846-0606","authenticated-orcid":false,"given":"Gyung-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4964_CR1","doi-asserted-by":"publisher","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u20131222. https:\/\/doi.org\/10.1016\/s0140-6736(20)30925-9 (2020).","DOI":"10.1016\/s0140-6736(20)30925-9"},{"key":"4964_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/s0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar, N. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 375, 2215\u20132222. https:\/\/doi.org\/10.1016\/s0140-6736(10)60484-9 (2010).","journal-title":"Lancet"},{"key":"4964_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2009.476","volume":"301","author":"LH Young","year":"2009","unstructured":"Young, L. H. et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: A randomized controlled trial. JAMA 301, 1547\u20131555. https:\/\/doi.org\/10.1001\/jama.2009.476 (2009).","journal-title":"JAMA"},{"key":"4964_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa043175","volume":"353","author":"S Tsimikas","year":"2005","unstructured":"Tsimikas, S. et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N. Engl. J. Med. 353, 46\u201357. https:\/\/doi.org\/10.1056\/NEJMoa043175 (2005).","journal-title":"N. Engl. J. Med."},{"key":"4964_CR5","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1161\/strokeaha.119.026872","volume":"50","author":"Y Pan","year":"2019","unstructured":"Pan, Y., Li, H., Wang, Y., Meng, X. & Wang, Y. Causal effect of Lp(a) [Lipoprotein(a)] level on ischemic stroke and Alzheimer disease: A mendelian randomization study. Stroke 50, 3532\u20133539. https:\/\/doi.org\/10.1161\/strokeaha.119.026872 (2019).","journal-title":"Stroke"},{"key":"4964_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/circulationaha.121.053797","volume":"144","author":"MG Levin","year":"2021","unstructured":"Levin, M. G. et al. Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease. Circulation 144, 353\u2013364. https:\/\/doi.org\/10.1161\/circulationaha.121.053797 (2021).","journal-title":"Circulation"},{"key":"4964_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas, S. A test in context: Lipoprotein(a): Diagnosis, prognosis, controversies, and emerging therapies. J. Am. Coll. Cardiol. 69, 692\u2013711. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.042 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","volume":"382","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas, S. et al. Lipoprotein(a) reduction in persons with cardiovascular disease. N. Engl. J. Med. 382, 244\u2013255. https:\/\/doi.org\/10.1056\/NEJMoa1905239 (2020).","journal-title":"N. Engl. J. Med."},{"key":"4964_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jacc.2006.03.047","volume":"48","author":"M Hartmann","year":"2006","unstructured":"Hartmann, M. et al. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J. Am. Coll. Cardiol. 48, 446\u2013452. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.047 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.11909\/j.issn.1671-5411.2021.12.001","volume":"18","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Lipoprotein(a) is associated with coronary atheroma progression: Analysis from a serial coronary computed tomography angiography study. J. Geriatr. Cardiol. 18, 996\u20131007. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2021.12.001 (2021).","journal-title":"J. Geriatr. Cardiol."},{"key":"4964_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jacc.2021.10.044","volume":"79","author":"Y Kaiser","year":"2022","unstructured":"Kaiser, Y. et al. Association of Lipoprotein(a) with atherosclerotic plaque progression. J. Am. Coll. Cardiol. 79, 223\u2013233. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.044 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2337\/dc19-0274","volume":"42","author":"JL Jin","year":"2019","unstructured":"Jin, J. L. et al. Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and prediabetes or diabetes. Diabetes Care 42, 1312\u20131318. https:\/\/doi.org\/10.2337\/dc19-0274 (2019).","journal-title":"Diabetes Care"},{"key":"4964_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2018.12.022","volume":"282","author":"A Saeed","year":"2019","unstructured":"Saeed, A. et al. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The atherosclerosis risk in communities study. Atherosclerosis 282, 52\u201356. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.022 (2019).","journal-title":"Atherosclerosis"},{"key":"4964_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2021.09.027","volume":"349","author":"H Lee","year":"2022","unstructured":"Lee, H. et al. Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals. Atherosclerosis 349, 190\u2013195. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.027 (2022).","journal-title":"Atherosclerosis"},{"key":"4964_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/circoutcomes.114.001305","volume":"7","author":"GM Park","year":"2014","unstructured":"Park, G. M. et al. Model for assessing cardiovascular risk in a Korean population. Circ. Cardiovasc. Qual. Outcomes 7, 944\u2013951. https:\/\/doi.org\/10.1161\/circoutcomes.114.001305 (2014).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"4964_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-t","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston, A. S. et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15, 827\u2013832. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-t (1990).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jacc.2005.10.058","volume":"47","author":"AW Leber","year":"2006","unstructured":"Leber, A. W. et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: A comparative study using intravascular ultrasound. J. Am. Coll. Cardiol. 47, 672\u2013677. https:\/\/doi.org\/10.1016\/j.jacc.2005.10.058 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.cir.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837\u20131847. https:\/\/doi.org\/10.1161\/01.cir.97.18.1837 (1998).","journal-title":"Circulation"},{"key":"4964_CR19","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff, D. C. Jr. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129, S49-73. https:\/\/doi.org\/10.1161\/01.cir.0000437741.48606.98 (2014).","journal-title":"Circulation"},{"key":"4964_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s0195-668x(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy, R. M. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 24, 987\u20131003. https:\/\/doi.org\/10.1016\/s0195-668x(03)00114-3 (2003).","journal-title":"Eur. Heart J."},{"key":"4964_CR21","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.2337\/diacare.27.8.1954","volume":"27","author":"FJ Wackers","year":"2004","unstructured":"Wackers, F. J. et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 27, 1954\u20131961. https:\/\/doi.org\/10.2337\/diacare.27.8.1954 (2004).","journal-title":"Diabetes Care"},{"key":"4964_CR22","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1161\/cir.0000000000000677","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett, D. K. et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140, e563\u2013e595. https:\/\/doi.org\/10.1161\/cir.0000000000000677 (2019).","journal-title":"Circulation"},{"key":"4964_CR23","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx, N. et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur. Heart J. 44, 4043\u20134140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192 (2023).","journal-title":"Eur. Heart J."},{"key":"4964_CR24","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/circulationaha.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang, C. C., Hess, C. N., Hiatt, W. R. & Goldfine, A. B. Clinical update: Cardiovascular disease in diabetes mellitus: Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation 133, 2459\u20132502. https:\/\/doi.org\/10.1161\/circulationaha.116.022194 (2016).","journal-title":"Circulation"},{"key":"4964_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2337\/dc06-2094","volume":"30","author":"JJ Bax","year":"2007","unstructured":"Bax, J. J. et al. Cardiac imaging for risk stratification in diabetes. Diabetes Care 30, 1295\u20131304. https:\/\/doi.org\/10.2337\/dc06-2094 (2007).","journal-title":"Diabetes Care"},{"key":"4964_CR26","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/eurheartj\/eht293","volume":"34","author":"M Hadamitzky","year":"2013","unstructured":"Hadamitzky, M. et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur. Heart J. 34, 3277\u20133285. https:\/\/doi.org\/10.1093\/eurheartj\/eht293 (2013).","journal-title":"Eur. Heart J."},{"key":"4964_CR27","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2337\/dc12-2123","volume":"36","author":"D Andreini","year":"2013","unstructured":"Andreini, D. et al. Prognostic value of multidetector computed tomography coronary angiography in diabetes: Excellent long-term prognosis in patients with normal coronary arteries. Diabetes Care 36, 1834\u20131841. https:\/\/doi.org\/10.2337\/dc12-2123 (2013).","journal-title":"Diabetes Care"},{"key":"4964_CR28","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jcmg.2016.01.040","volume":"9","author":"SH Kang","year":"2016","unstructured":"Kang, S. H. et al. Long-term prognostic value of coronary CT angiography in asymptomatic type 2 diabetes mellitus. JACC Cardiovasc. Imaging 9, 1292\u20131300. https:\/\/doi.org\/10.1016\/j.jcmg.2016.01.040 (2016).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"4964_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.amjcard.2021.05.019","volume":"153","author":"HW Park","year":"2021","unstructured":"Park, H. W. et al. Cholesterol control for subclinical coronary atherosclerosis in subjects without indication for statin therapy. Am. J. Cardiol. 153, 51\u201357. https:\/\/doi.org\/10.1016\/j.amjcard.2021.05.019 (2021).","journal-title":"Am. J. Cardiol."},{"key":"4964_CR30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.rec.2023.01.004","volume":"76","author":"J Hyun","year":"2023","unstructured":"Hyun, J. et al. Ten-year prognostic value of coronary CT angiography in asymptomatic patients with type 2 diabetes. Rev. Esp Cardiol. (Engl. Ed.) 76, 700\u2013707. https:\/\/doi.org\/10.1016\/j.rec.2023.01.004 (2023).","journal-title":"Rev. Esp Cardiol. (Engl. Ed.)"},{"key":"4964_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","volume":"62","author":"JJ Albers","year":"2013","unstructured":"Albers, J. J. et al. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: The AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL\/High Triglyceride and Impact on Global Health Outcomes). J. Am. Coll. Cardiol. 62, 1575\u20131579. https:\/\/doi.org\/10.1016\/j.jacc.2013.06.051 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/circulationaha.113.004406","volume":"129","author":"AV Khera","year":"2014","unstructured":"Khera, A. V. et al. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: An analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Circulation 129, 635\u2013642. https:\/\/doi.org\/10.1161\/circulationaha.113.004406 (2014).","journal-title":"Circulation"},{"key":"4964_CR33","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/circulationaha.118.037184","volume":"139","author":"ML O'Donoghue","year":"2019","unstructured":"O\u2019Donoghue, M. L. et al. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation 139, 1483\u20131492. https:\/\/doi.org\/10.1161\/circulationaha.118.037184 (2019).","journal-title":"Circulation"},{"key":"4964_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","volume":"75","author":"VA Bittner","year":"2020","unstructured":"Bittner, V. A. et al. Effect of alirocumab on Lipoprotein(a) and cardiovascular risk after acute coronary syndrome. J. Am. Coll. Cardiol. 75, 133\u2013144. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.057 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4964_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/ehjcvp\/pvad019","volume":"9","author":"E Imbalzano","year":"2023","unstructured":"Imbalzano, E. et al. The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Eur. Heart J. Cardiovasc. Pharmacother. 9, 318\u2013327. https:\/\/doi.org\/10.1093\/ehjcvp\/pvad019 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04964-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:19:16Z","timestamp":1751375956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04964-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4964"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04964-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20436"}}